EUVIMEDEUVIMED entdecken
Crossref

Eradication of Staphylococcus aureus in Implant-Associated Osteomyelitis by an Injectable In Situ-Forming Depot Antibiotics Delivery System

Albert Juan Fuglsang-Madsen iD, Nicole Lind Henriksen, Elizabeth Serrano Chávez, Lasse Andersson Kvich, Julie Knippel Melsted Birch, Katrine Top Hartmann, Thomas Eriksen, Thomas Bjarnsholt iD, Hans Gottlieb, Thomas Lars Andresen, Louise Kruse Jensen, Jonas Rosager Henriksen und 1 weitere

The Journal of Infectious Diseases · 23.09.2024 · 230 (3) · 614-623

DOI: 10.1093/infdis/jiae139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 27.03.2024. Verfasst von Albert Juan Fuglsang-Madsen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark. Hauptthemen laut MEDLINE: Osteomyelitis, Anti-Bacterial Agents, Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Novo Nordisk Foundation, Innovation Fund Denmark.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bone infections with Staphylococcus aureus are notoriously difficult to treat and have high recurrence rates. Local antibiotic delivery systems hold the potential to achieve high in situ antibiotic concentrations, which are otherwise challenging to achieve via systemic administration. Existing solutions have been shown to confer suboptimal drug release and distribution. Here we present and evaluate an injectable in situ-forming depot system termed CarboCell. The CarboCell technology provides sustained and tuneable release of local high-dose antibiotics.

Methods

CarboCell formulations of levofloxacin or clindamycin with or without antimicrobial adjuvants cis-2-decenoic acid or cis-11-methyl-2-dodecenoic acid were tested in experimental rodent and porcine implant-associated osteomyelitis models. In the porcine models, debridement and treatment with CarboCell-formulated antibiotics was carried out without systemic antibiotic administration. The bacterial burden was determined by quantitative bacteriology.

Results

CarboCell formulations eliminated S. aureus in infected implant rat models. In the translational implant-associated pig model, surgical debridement and injection of clindamycin-releasing CarboCell formulations resulted in pathogen-free bone tissues and implants in 9 of 12 and full eradication in 5 of 12 pigs.

Conclusions

Sustained release of antimicrobial agents mediated by the CarboCell technology demonstrated promising therapeutic efficacy in challenging translational models and may be beneficial in combination with the current standard of care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteomyelitisAnti-Bacterial AgentsStaphylococcus aureusStaphylococcal InfectionsClindamycinAnimalsSwineRatsDisease Models, AnimalDrug Delivery SystemsLevofloxacinDelayed-Action PreparationsFemale

Stichwörter der Autor:innen

Staphylococcus aureusCarboCellantibioticsbiofilm infectioncontrolled drug releasedrug deliveryexperimental animal modelsimplant-associated osteomyelitisosteomyelitistranslational science

Substanzen

Anti-Bacterial AgentsClindamycinLevofloxacinDelayed-Action Preparations

Autor:innen und Institutionen

  • Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Department of Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, Denmark.
  • Costerton Biofilm Centre, Institute of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Department of Clinical Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Department of Orthopedic Surgery, Herlev Hospital, Herlev, Denmark.

ORCID-Profile: Albert Juan Fuglsang-Madsen, Thomas Bjarnsholt, Anders Elias Hansen

Förderung

  • Novo Nordisk Foundation
  • Innovation Fund Denmark

Zitieren

APA

Fuglsang-Madsen, A. J., Henriksen, N. L., Chávez, E. S., Kvich, L. A., Birch, J. K. M., Hartmann, K. T., Eriksen, T., Bjarnsholt, T., Gottlieb, H., Andresen, T. L., Jensen, L. K., Henriksen, J. R., & Hansen, A. E. (2024). Eradication of Staphylococcus aureus in Implant-Associated Osteomyelitis by an Injectable In Situ-Forming Depot Antibiotics Delivery System. The Journal of Infectious Diseases, 230(3), 614-623. https://doi.org/10.1093/infdis/jiae139

Vancouver

Fuglsang-Madsen AJ, Henriksen NL, Chávez ES, Kvich LA, Birch JKM, Hartmann KT, et al. Eradication of Staphylococcus aureus in Implant-Associated Osteomyelitis by an Injectable In Situ-Forming Depot Antibiotics Delivery System. The Journal of Infectious Diseases. 2024;230(3):614-623. doi:10.1093/infdis/jiae139

BibTeX
@article{FuglsangMadsen2024,
  author = {Fuglsang-Madsen, Albert Juan and Henriksen, Nicole Lind and Chávez, Elizabeth Serrano and Kvich, Lasse Andersson and Birch, Julie Knippel Melsted and Hartmann, Katrine Top and Eriksen, Thomas and Bjarnsholt, Thomas and Gottlieb, Hans and Andresen, Thomas Lars and Jensen, Louise Kruse and Henriksen, Jonas Rosager and Hansen, Anders Elias},
  title = {Eradication of Staphylococcus aureus in Implant-Associated Osteomyelitis by an Injectable In Situ-Forming Depot Antibiotics Delivery System},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  volume = {230},
  number = {3},
  pages = {614--623},
  doi = {10.1093/infdis/jiae139}
}
Kostenlos starten →